Corrigendum to “Remodeling tumor immunosuppressive microenvironment via a novel bioactive nanovaccines potentiates the efficacy of cancer immunotherapy” [Bioactive Mater. 16 107–119]

The authors regret that the published version of the above article contained two errors which were not identified during the proofing stage. Also, Figure 2A and 6C have been replaced. The authors apologize for these errors and state that these corrections do not change the scientific conclusions of the article in any way.

Fig. 2. (A) Representative confocal fluorescence images of bone marrow-derived dendritic cells (BMDCs) after incubation with BN@HM-OVA-FITC (green) for 2 h and 6 h at pH 7.4 and pH 6.8, respectively. BMDCs were labeled with Dil (red). Scale bars = 50 μm.

Fig. 6. (C) Representative flow cytometric analysis of CD4+/CD8+ T cell populations gating on CD3⁺ cells in tumor.

Declaration of competing interest

The authors claim no conflicts of interest.